From the Journals

COVID-19 Increases Autoimmune Blistering Disease Risk, Study Finds

COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records

Share

6 Key Takeaways

  • 1

    COVID-19 infections linked to increased risk of autoimmune blistering diseases (AIBD).

  • 2

    COVID-19 vaccination associated with reduced risk of AIBD.

  • 3

    Study involved over 112 million patients.

  • 4

    Limitations due to retrospective design.

  • 5

    Emphasized need for monitoring autoimmune diseases post-COVID-19 infection.

  • 6

    Highlighted broader benefits of vaccination beyond infection prevention.

Original Source(s)

COVID-19 Increases Autoimmune Blistering Disease Risk, Study Finds

COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records

  • by Stanley Gajete

  • March 6, 2025

  • 2 min

Related Content

AD Pain, Sleep Scales Validated in Phase 3 Trials

What meaningful change looks like on skin pain and sleep disturbance scales

Rapid Itch Relief Seen with Nemolizumab

Researchers examined early itch and sleep outcomes with interleukin-31 pathway inhibition in atopic dermatitis and prurigo nodularis in phase 3 trial analyses.

Wildfires May Have Triggered Skin Disease Flare-ups in Northeastern United States

The number of visits to dermatologists for atopic dermatitis and eczema may have increased during the summer months of 2023 following the Canadian wildfires.